Skip to main content
. 2015 Sep 29;10(9):e0139310. doi: 10.1371/journal.pone.0139310

Table 1. Baseline subject characteristics between subjects with and without NAFLD (n = 797).

No NAFLD (n = 577) NAFLD (n = 220) P 1 Age and sex adjusted P 2
Age (years) 47.0 ± 10.8 3 51.0 + 9.3 <0.001 —-
BMI (kg/m2) 21.7 ± 3.0 25.5 + 3.5 <0.001 <0.001
WC (cm) 78.4 ± 9.2 89.2 + 7.6 <0.001 <0.001
Male [n (%)] 214 (37.1) 118 (53.6) <0.001 —-
Current smoker [n (%)] 48 (8.3) 19 (8.6) 0.885 0.504
Current drinker [n (%)] 96 (16.6) 55 (25.0) 0.007 0.177
MDS 4.0 ± 1.7 3 4.0 + 1.8 0.904 0.068
DQI-I 57.9 ± 10.4 57.2 + 11.5 0.368 0.007
SBP (mmHg) 126.1 ± 19.0 137.8 + 19.0 <0.001 <0.001
DBP (mmHg) 79.2 ± 11.3 88.3 + 12.6 <0.001 <0.001
Alanine aminotransferase (IU/l) 19 (15–25) 31 (23–42) <0.001 4 <0.001
Fasting glucose (mmol/l) 4.9 (4.6–5.2) 5.2 (4.9–5.6) <0.001 4 <0.001
Total cholesterol (mmol/l) 5.1 + 1.0 5.4 + 1.0 <0.001 0.012
HDL-cholesterol (mmol/l) 1.6 + 0.4 1.3 + 0.3 <0.001 <0.001
Triglycerides (mmol/l) 0.9 (0.7–1.2) 1.6 (1.2–2.3) <0.001 4 <0.001
LDL-cholesterol (mmol/l) 2.9 ± 0.8 3.2 + 0.9 <0.001 0.002
Central obesity 5 [n (%)] 160 (27.7) 143 (65.0) <0.001 <0.001
Triglycerides > 1.7 mmol/l 5 [n (%)] 63 (10.9) 97 (44.1) <0.001 <0.001
Reduced HDL-cholesterol 5 [n (%)] 45 (7.8) 64 (29.1) <0.001 <0.001
Hypertension 5 [n (%)] 251 (43.5) 161 (73.2) <0.001 <0.001
Impaired fasting glucose or DM 5 [n (%)] 53 (9.2) 61 (27.7) <0.001 <0.001
Metabolic syndrome 5 [n (%)] 45 (7.8) 105 (47.7) <0.001 <0.001
PNPLA3 genotypes [n (%)]
 CC 248 (43.1) 63 (28.6) <0.001 <0.001
 CG 265 (46.0) 115 (52.3)
 GG 63 (10.9) 42 (19.1)
Intrahepatic triglyceride content (%) 1.2 (0.7–2.4) 9.8 (7.0–15.4) <0.001 4 <0.001

1 Group difference by independent t test for continuous variables and chi-squared or Fisher exact test for categorical variables unless otherwise stated

2 Group difference by ANCOVA for continuous variables and logistic regression for categorical variables unless otherwise stated

3 Mean ± SD or median (interquarter range) (all such values) unless otherwise stated

4 Group difference by nonparametric Mann-Whiney U test

5 International Diabetes Federation criteria for metabolic syndrome [38]

BMI, body mass index; DBP, diastolic blood pressure; DM, diabetes mellitus; DQI-I, Diet Quality Index-International; MDS, Mediterranean Diet Score; NAFLD, nonalcoholic fatty liver disease; SBP, systolic blood pressure; WC, waist circumference